Table 2.

IPC activities, recommended treatment, and criteria for discontinuation of self-isolation for COVID-19 patients as perceived by pharmacists.

Course of actions (IPC) followed by pharmacists to minimize the spread of COVID19	Frequency (%)					Mean (SD)
	Never	Less Often	Sometimes	Often	Very Often
Nothing, wait and see	46 (9.5)	167 (34.4)	187 (38.5)	81 (16.7)	5 (1.0)	2.65 (0.90)
Covering nose and mouth when sneezing	10 (2.1)	29 (5.7)	26 (5.3)	324 (66.7)	97 (20.0)	3.95 (0.87)
Request medical help immediately	18 (3.7)	120 (24.7)	147 (30.0)	183 (37.7)	19 (3.9)	3.14 (0.95)
Self-isolation and request sick leave	14 (2.9)	16 (3.3)	14 (2.9)	264 (54.3)	178 (36.6)	4.19 (0.87)
Take antibiotics	130 (26.7)	165 (34.0)	168 (34.6)	15 (3.1)	8 (1.6)	2.19 (0.92)
Herbal products	25 (5.1)	114 (23.5)	229 (47.1)	104 (21.4)	14 (2.9)	2.93 (0.87)
Over the counter (OTC) medications	78 (16.0)	24 (4.9)	108 (22.2)	232 (47.7)	44 (9.1)	3.29 (1.20)
Wear face mask	107 (22.0)	125 (25.7)	126 (25.9)	120 (24.7)	8 (1.6)	2.58 (1.13)
Undergo testing for COVID-19	52 (10.7)	60 (12.3)	46 (9.5)	242 (49.8)	86 (17.7)	3.51 (1.22)
Stop socializing	15 (3.1)	5 (1.0)	27 (5.6)	311 (64.0)	128 (26.3)	4.09 (0.79)
Clean surrounding surfaces	13 (2.7)	20 (4.1)	41 (8.4)	348 (71.6)	64 (13.2)	3.88 (0.78)

Recommended treatment approach for controlling COVID-19	Frequency ‘Yes’ (%)
No treatment available	398 (81.9)
Antivirals	115 (23.7)
Vitamin C	162 (33.3)
Treating complications (supportive care)	348 (71.6)
Observation and follow-up	144 (29.6)
Antibacterial	7 (1.4)

Conditions to discontinue self-isolation of COVID 19 diagnosed patients	Frequency ‘Correct Answer’ (%)
Resolution of fever with the use of fever-reducing medications (correct answer: No)	266 (54.7)
Improvement in respiratory symptoms (e.g., cough, shortness of breath) (correct answer: Yes)	232 (47.7)
Negative results of an FDA emergency use authorized molecular assay for COVID-19 from at least two consecutive nasopharyngeal swab specimens collected ≥24 h apart (correct answer: Yes)	371 (76.3)